Noncash Stock Compensation: Estimated $41 million for full-year 2024. Syndax Pharmaceuticals Inc (NASDAQ:SNDX) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback